Drug Research

Strategic oversight and regulatory navigation in the pharmaceutical industry rely on an integrated approach to drug development consulting, ensuring that global clinical pipelines reach the market efficiently.

It may sound like science fiction to the layperson, but cryopreservation is here, and it’s bridging the gap between what’s medically possible today and the potential of future technologies. This technology sits at the intersection of biotechnology, medicine and...

ICON, a world-leading clinical research organisation, has formalised a definitive partnership agreement with Advarra to introduce a new research-ready trial model designed to reshape how clinical trials are conducted. The collaboration brings together ICON’s global clinical trial solutions with...

Novartis is stepping up its presence in China with a fresh wave of capital deployment, underscoring the country’s growing role in global pharmaceutical strategy. The company confirmed a Novartis China investment exceeding 3.3 billion Chinese yuan (roughly $480 million),...

Egypt is stepping up its push to reinforce its pharmaceutical research landscape by deepening pharmaceutical cooperation with Takeda Pharmaceutical Company, aligning with a wider national agenda to strengthen healthcare capabilities and drug development infrastructure. In this context, the Egyptian Drug...

The demand for online medicine delivery in India has grown rapidly as patients seek convenience without compromising on authenticity. With chronic digestive disorders on the rise, many physicians prescribe combination therapies such as Ganaton Total to manage complex gastrointestinal symptoms....

Swiss drugmaker Roche has expanded its artificial intelligence infrastructure by deploying more than 2,100 NVIDIA chips, strengthening its computational capabilities to accelerate drug and diagnostics development. The move, centred on a large-scale Roche AI factory, reflects the company’s ongoing...